Cover Image

Inhaled Corticosteroids Versus Placebo for Stable Chronic Obstructive Pulmonary Disease

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Erin Kamalanathan, Sargam Sharma
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Clinical & Experimental Allergy
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

National and Individual‐Level Economic Burden of Local Corticosteroid Use and Concomitant Use of Multiple Local Corticosteroid Formulations—A Nationwide Cohort Study
by: Kjell Erik Julius Håkansson, et al.
Published: (2026)

Comparative Efficacy of Intranasal Corticosteroids and Antihistamines in Enhancing Paediatric Quality of Life in Allergic Rhinoconjunctivitis
by: Ellen Tameeris, et al.
Published: (2026)

Low CCR3 Expression Is a Marker of Active Disease in Chronic Spontaneous Urticaria
by: Crisjana Bellamy, et al.
Published: (2024)

Clinical Characteristics, Treatment Patterns and Outcomes of Oral Corticosteroid–Dependent Asthma in Real‐World Practice: A Nationwide Population‐Based Study in Korea
by: Hyun Lee, et al.
Published: (2025)

Gender‐Dependent Differences in Serum Osteopontin Levels in Chronic Spontaneous Urticaria: A Link to Disease Activity in Females
by: Hongshan Liu, et al.
Published: (2026)

Lymphopenia in Chronic Spontaneous Urticaria is Linked to Basopenia and Eosinopenia
by: Mojca Bizjak, et al.
Published: (2024)

Investigation of the Pathomechanism of Chronic Cough Using an In Vitro Approach
by: Umesh Singh, et al.
Published: (2025)

Global Incidence and Prevalence of Chronic Rhinosinusitis: A Systematic Review
by: Hye Kyu Min, et al.
Published: (2024)

Mas‐Related G‐Protein Coupled Receptor‐X2 and Chemokine (C–C Motif) Ligand 2 Correlate With Disease Activity Among Treatment‐Naïve Chinese Patients With Chronic Spontaneous Urticaria
by: Kristie Lao, et al.
Published: (2024)

Mapping the Burden and Risk Factors of Allergic Diseases and Asthma Among Aboriginal and Torres Strait Islander People: A Scoping Review
by: Desalegn Markos Shifti, et al.
Published: (2025)

Psychometric Validation of the Traditional Chinese Chronic Urticaria Quality of Life Questionnaire
by: Hugo W. F. Mak, et al.
Published: (2024)

The Incidence of Addiction and Its Risk Factors in Chinese Chronic Urticaria Patients
by: Xinyu Shui, et al.
Published: (2025)

Perceived Acquired Resistance to Omalizumab in Obese Patients With Chronic Spontaneous Urticaria
by: Francisco Martins, et al.
Published: (2026)

Asthma is Underdiagnosed and Often Uncontrolled in Preoperative Patients With Chronic Rhinosinusitis With Nasal Polyps
by: Emma Genberg, et al.
Published: (2024)

Temporal Trends in the Course and Management of Chronic Urticaria at a European Tertiary Center
by: Clara Emilie Syrene Østergaard, et al.
Published: (2025)

Prevalence of Metabolic Syndrome in Chronic Urticaria: A Systematic Review and Meta‐Analysis
by: Daniel G. Rayner, et al.
Published: (2025)

Treatment Approach to Chronic Rhinosinusitis Based on Endotype: Difference Between East and West
by: Junhai Chen, et al.
Published: (2025)

Towards Personalised Therapy in Chronic Spontaneous Urticaria: Advancing From Endotype to Clinical Response
by: Katie Ridge, et al.
Published: (2025)

Population‐Scale Plasma Proteomics Reveals Systemic Inflammatory Signatures Associated With Chronic Rhinosinusitis
by: Dachan Kim, et al.
Published: (2026)

Reframing Personalised Therapy in Chronic Spontaneous Urticaria: Beyond Endotypes Toward Mechanistic Response Profiling
by: Nav La, et al.
Published: (2025)

Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes
by: Alessandra Vultaggio, et al.
Published: (2026)

Distinct Cytokine Profiles in Chronic Spontaneous Urticaria Refractory to H1 ‐Antihistamines Compared to Healthy Controls
by: Young‐Min Ye, et al.
Published: (2025)

Increased TRPV6 Potentiates Interleukin‐13 Signalling in Epithelial Cells in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
by: Fuying Cheng, et al.
Published: (2026)

Efficacy and Safety of Oral Cyclosporine in Antihistamine Refractory Chronic Urticaria Among Children and Adolescents: A Retrospective Study
by: Davinder Parsad, et al.
Published: (2025)

Emerging Role of SAMSN1+Mast Cells: Insights From Mendelian Randomisation and Transcriptomic Analyses on Chronic Sinusitis and Obesity
by: Shican Zhou, et al.
Published: (2024)

Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
by: Reineke Soegiharto, et al.
Published: (2025)

Body Mass Index Is Not Associated With Cough, Laryngeal Hypersensitivity or Dyspnoea in Patients With Refractory Chronic Cough: A Cross‐Sectional Study
by: Tina Wilkie, et al.
Published: (2026)

Excessive Endoplasmic Reticulum Stress in B Cells Associates With the Local Immunoglobulin Production in Severe Type 2 Chronic Rhinosinusitis With Nasal Polyps
by: Yanran Huang, et al.
Published: (2025)

Exploring the Disease Duration of Urticaria and Associated Determinants in Primary Care
by: R. Soegiharto, et al.
Published: (2025)

A Role for Non‐Canonical Caspases in Fungal Allergic Airway Disease
by: Thomas J. Williams, et al.
Published: (2026)

The Causal Relationship Between Serum Metabolites and Allergic Diseases: Mendelian Randomization Analysis
by: Yanli Qiu, et al.
Published: (2024)

Allergic Diseases and Triglyceride‐Related Lipid Profiles in Nationally Representative Korean Adults
by: Yu Kyoung Hwang, et al.
Published: (2026)

Global Modelling Links Maternal Hypertensive Disorders to Early Childhood Allergic Disease Burden
by: Duan Ni, et al.
Published: (2024)

IgE Antibody Associations With Allergic Disease Phenotypes Using ISAC and ALEX Assays
by: Enrico Scala, et al.
Published: (2024)

Asthma and Atopic Dermatitis in Asia, 1990–2021: The Global Burden of Disease Study 2021
Published: (2025)

Impact of Birth Order on Paediatric Allergic Diseases: A National Birth Cohort in Japan
by: Mitsuro Kobayashi, et al.
Published: (2025)

Systemic N‐Acylethanolamines and Other Lipid Mediators Are Associated With NSAID ‐Exacerbated Respiratory Disease
by: Viljami E. Salmi, et al.
Published: (2025)

Prevalence and Sociodemographic Variation of Allergic Diseases in Australia: Findings From the Australian National Health Survey
by: Yichao Wang, et al.
Published: (2026)

Two Distinct Transcriptional Subtypes of Severe Type 2 Asthma in NSAID ‐Exacerbated Respiratory Disease
by: Radosław Kacorzyk, et al.
Published: (2026)

Onset and Offset of Early Dupilumab Response Using Domiciliary Monitoring in Type 2 High Unified Airway Disease
by: Kirsten Stewart, et al.
Published: (2024)